Showing results (6301-6310 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|January 1, 2010
Muscular dystrophies: histology, immunohistochemistry, molecular genetics and managementLamperti Costanza, Maurizio MoggioCurrent Pharmaceutical Design|November 25, 2005
Indolyl aryl sulfones (IASs): development of highly potent NNRTIs active against wt-HIV-1 and clinically relevant drug resistant mutantsRomano Silvestri, Marino ArticoCurrent Pharmaceutical Design|November 25, 2005
Ubiquitin-proteasome pathway components as therapeutic targets for CNS maladiesSudarshan C Upadhya, Ashok N HegdeCurrent Pharmaceutical Design|November 25, 2005
The antiviral activity, mechanism of action, clinical significance and resistance of abacavir in the treatment of pediatric AIDSJoel Melroy, Vasu NairCurrent Pharmaceutical Design|November 25, 2005
Direct thrombin inhibitors for the treatment of acute coronary syndromes and during percutaneous coronary interventionsG Paoli, P A Merlini, D ArdissinoCurrent Pharmaceutical Design|November 25, 2005
Direct thrombin inhibitors for treatment of heparin induced thrombocytopenia, deep vein thrombosis and atrial fibrillationC W FrancisCurrent Pharmaceutical Design|October 29, 2009
Non-canonical peptides bound to MHCStephanie L Day, Paul A Ramsland, Vasso ApostolopoulosCurrent Pharmaceutical Design|October 29, 2009
The TCR/CD3 complex: opening the gate to successful vaccinationPilar Portolés, Jose M RojoCurrent Pharmaceutical Design|October 29, 2009
NK cell receptors and their interactions with MHCRoberto Biassoni, Elisabetta Ugolotti, Andrea De MariaCurrent Pharmaceutical Design|October 29, 2009
Presentation of lipid antigens by CD1 glycoproteinsAndré Schiefner, Ian A WilsonPageof 1,008